Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People In Brief

This article was originally published in The Tan Sheet

Executive Summary

Changes at P&G: Procter & Gamble North America President Ed Shirley will become global beauty & grooming vice chairman, the company announces June 12. Steve Bishop, currently North America market operations president, replaces Shirley as president. Both moves are effective July 1. P&G CEO A.G. Lafley says Shirley and Bishop "have delivered consistently strong growth in the North America business over the past two years, in the face of intensifying economic and competitive pressure"...

You may also be interested in...



People In Brief

CHPA board: The Consumer Health Products Association elects to its board Roger Scarlett-Smith, recently appointed president of GlaxoSmithKline's North American Consumer Healthcare Division, and Scott Emerson, founder and president of The Emerson Group consulting firm. According to a June 27 release, Scarlett-Smith has also held executive posts for GSK businesses in the U.K. and in Australia and New Zealand, as well as for Procter & Gamble in the U.K. Emerson is a principal at marketing firm DSE Healthcare Solutions and has worked in brand management, business development and sales for Johnson & Johnson, Novartis and Unilever...

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS101802

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel